Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Tumor Necrosis Factor Receptor Blocking Activity [MoA]: Side Effects & Safety Data for 6 Drugs

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Tumor Necrosis Factor Receptor Blocking Activity [MoA] includes 6 drugs with a combined 1,192,235 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.

6
Drugs in Class
1,192,235
Combined Reports

All Tumor Necrosis Factor Receptor Blocking Activity [MoA] Drugs Ranked by Reports

Drug Brand Name Reports Deaths Hosp. Death Rate
ADALIMUMAB YUSIMRY 499,856 21,807 108,264 4.4%
ETANERCEPT ENBREL 358,285 10,338 36,932 2.9%
INFLIXIMAB Renflexis 140,189 7,516 36,324 5.4%
CERTOLIZUMAB PEGOL Cimzia 99,098 5,361 17,641 5.4%
GOLIMUMAB SIMPONI ARIA 69,222 4,866 15,471 7.0%
INFLIXIMAB-DYYB ZYMFENTRA 25,585 632 6,251 2.5%

Common Side Effects in Tumor Necrosis Factor Receptor Blocking Activity [MoA] Drugs

Side EffectReportsDeaths
Drug ineffective 210,940 7,129
Pain 111,997 8,458
Rheumatoid arthritis 109,630 9,065
Off label use 104,697 10,206
Arthralgia 98,038 8,269
Fatigue 86,975 9,412
Condition aggravated 67,177 7,661
Rash 63,955 8,828
Joint swelling 63,879 9,076
Drug intolerance 57,455 6,777
View detailed side effects for this class → Compare drugs in this class →